Model for End-Stage Liver Disease (MELD) exception for hepatopulmonary syndrome

Liver Transplantation

Volumn 12, Issue 12 SUPPL. 3, 2006, Pages

  Fallon, Michael B ^a   Mulligan, David C ^b   Gish, Robert G ^c   Krowka, Michael J ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MAYO CLINIC   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROSALB TC 99M;

ARTERIAL OXYGEN TENSION; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MODEL; HEPATOPULMONARY SYNDROME; HUMAN; HYPOXEMIA; INFORMATION PROCESSING; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; LUNG BLOOD VESSEL; LUNG FUNCTION TEST; PORTAL HYPERTENSION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULSE OXIMETRY; SCINTISCANNING; SCREENING TEST; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT INDICATION; VASODILATATION;

HEPATOPULMONARY SYNDROME; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MODELS, BIOLOGICAL; SEVERITY OF ILLNESS INDEX; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TISSUE AND ORGAN PROCUREMENT;

EID: 33845494960     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20971     Document Type: Article

References (13)

1. Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB, for the ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 2004;24:861-880.
2. Abrams GA, Jaffe CC, Hoffer PB, Binder HJ, Fallon MB. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995;109:1283-1288.
3. Abrams GA, Sanders MK, Fallon MB. Utility of pulse oximetry in the detection of arterial hypoxemia in liver transplant candidates. Liver Transpl 2002;8:391-396.
4. Krowka MJ, Mandell S, Ramsay MA, Kawut S, Fallon MB, Manzarbeitia C, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 2004; 10: 174-182.
5. Martinez G, Barbera J, Visa J, Rimola A, Parc J, Roca J, et al. Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol 2001;34:756-758.
6. Schenk P, Fuhrmann V, Madl C, Funk G, Lehr S, Kandel O, et al. Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences. Gut 2002;51:853-859.
7. Schenk P, Schoniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Muller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003;125:1042-1052.
8. Abrams G, Nanda N, Dubovsky E, Krowka M, Fallon M. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology 1998;114:305-310.
9. Arguedas M, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 2003;37:192-197.
10. Martinez G, Barbera J, Navasa M, Roca J, Visa J, Rodriguez-Roisin R. Hepatopulmonary syndrome associated with cardiorespiratory disease. J Hepatol 1999;30:882-889.
11. Swanson K, Wiesner R, Krowka M. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology 2005;41:1122-1129.
12. Sulieman B, Voigt M, Katz D, Hunsicker L. Data driven policy for points allocation in hepatopulmonary syndrome. Hepatology 2005;42:347A.
13. Taille C, Cadranel J, Bellocq A, Thabut G, Soubrane O, Durand F, et al. Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France. Transplantation 2003;79:1482-1489.